336 related articles for article (PubMed ID: 20943670)
1. CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease.
Rogacev KS; Seiler S; Zawada AM; Reichart B; Herath E; Roth D; Ulrich C; Fliser D; Heine GH
Eur Heart J; 2011 Jan; 32(1):84-92. PubMed ID: 20943670
[TBL] [Abstract][Full Text] [Related]
2. Human monocyte heterogeneity--a nephrological perspective.
Rogacev KS; Heine GH
Nephrol Ther; 2010 Jul; 6(4):219-25. PubMed ID: 20447885
[TBL] [Abstract][Full Text] [Related]
3. Elevated CD14++CD16- monocytes predict cardiovascular events.
Berg KE; Ljungcrantz I; Andersson L; Bryngelsson C; Hedblad B; Fredrikson GN; Nilsson J; Björkbacka H
Circ Cardiovasc Genet; 2012 Feb; 5(1):122-31. PubMed ID: 22238190
[TBL] [Abstract][Full Text] [Related]
4. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.
Rogacev KS; Cremers B; Zawada AM; Seiler S; Binder N; Ege P; Große-Dunker G; Heisel I; Hornof F; Jeken J; Rebling NM; Ulrich C; Scheller B; Böhm M; Fliser D; Heine GH
J Am Coll Cardiol; 2012 Oct; 60(16):1512-20. PubMed ID: 22999728
[TBL] [Abstract][Full Text] [Related]
5. Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease.
Ulrich C; Heine GH; Seibert E; Fliser D; Girndt M
Nephrol Dial Transplant; 2010 Jul; 25(7):2265-72. PubMed ID: 20150168
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of monocytic angiotensin-converting enzyme in dialysis patients with cardiovascular disease.
Ulrich C; Heine GH; Garcia P; Reichart B; Georg T; Krause M; Köhler H; Girndt M
Nephrol Dial Transplant; 2006 Jun; 21(6):1596-602. PubMed ID: 16476718
[TBL] [Abstract][Full Text] [Related]
7. CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients.
Heine GH; Ulrich C; Seibert E; Seiler S; Marell J; Reichart B; Krause M; Schlitt A; Köhler H; Girndt M
Kidney Int; 2008 Mar; 73(5):622-9. PubMed ID: 18160960
[TBL] [Abstract][Full Text] [Related]
8. Haemodialysis-induced transient CD16+ monocytopenia and cardiovascular outcome.
Rogacev KS; Ziegelin M; Ulrich C; Seiler S; Girndt M; Fliser D; Heine GH
Nephrol Dial Transplant; 2009 Nov; 24(11):3480-6. PubMed ID: 19586969
[TBL] [Abstract][Full Text] [Related]
9. Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity.
Merino A; Buendia P; Martin-Malo A; Aljama P; Ramirez R; Carracedo J
J Immunol; 2011 Feb; 186(3):1809-15. PubMed ID: 21191073
[TBL] [Abstract][Full Text] [Related]
10. Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease.
Rogacev KS; Zawada AM; Emrich I; Seiler S; Böhm M; Fliser D; Woollard KJ; Heine GH
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2120-7. PubMed ID: 25060791
[TBL] [Abstract][Full Text] [Related]
11. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction.
Tsujioka H; Imanishi T; Ikejima H; Kuroi A; Takarada S; Tanimoto T; Kitabata H; Okochi K; Arita Y; Ishibashi K; Komukai K; Kataiwa H; Nakamura N; Hirata K; Tanaka A; Akasaka T
J Am Coll Cardiol; 2009 Jul; 54(2):130-8. PubMed ID: 19573729
[TBL] [Abstract][Full Text] [Related]
12. Increased frequency and cell death of CD16+ monocytes with Mycobacterium tuberculosis infection.
Castaño D; García LF; Rojas M
Tuberculosis (Edinb); 2011 Sep; 91(5):348-60. PubMed ID: 21621464
[TBL] [Abstract][Full Text] [Related]
13. Monocyte subtypes predict clinical course and prognosis in human stroke.
Urra X; Villamor N; Amaro S; Gómez-Choco M; Obach V; Oleaga L; Planas AM; Chamorro A
J Cereb Blood Flow Metab; 2009 May; 29(5):994-1002. PubMed ID: 19293821
[TBL] [Abstract][Full Text] [Related]
14. Impact of different immunosuppressive regimens on antigen-presenting blood cells in kidney transplant patients.
Scherberich JE; Estner H; Segerer W
Kidney Blood Press Res; 2004; 27(3):177-80. PubMed ID: 15256814
[TBL] [Abstract][Full Text] [Related]
15. CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis.
Kawanaka N; Yamamura M; Aita T; Morita Y; Okamoto A; Kawashima M; Iwahashi M; Ueno A; Ohmoto Y; Makino H
Arthritis Rheum; 2002 Oct; 46(10):2578-86. PubMed ID: 12384915
[TBL] [Abstract][Full Text] [Related]
16. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
[TBL] [Abstract][Full Text] [Related]
17. CD14++CD16+ monocytes in patients with acute ischaemic heart failure.
Wrigley BJ; Shantsila E; Tapp LD; Lip GY
Eur J Clin Invest; 2013 Feb; 43(2):121-30. PubMed ID: 23240665
[TBL] [Abstract][Full Text] [Related]
18. Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14+ CD16+ monocytes in detoxification of oxidized LDL.
Mosig S; Rennert K; Krause S; Kzhyshkowska J; Neunübel K; Heller R; Funke H
FASEB J; 2009 Mar; 23(3):866-74. PubMed ID: 19001052
[TBL] [Abstract][Full Text] [Related]
19. Losartan prevents the development of the pro-inflammatory monocytes CD14+CD16+ in haemodialysis patients.
Merino A; Alvarez-Lara MA; Ramirez R; Carracedo J; Martin-Malo A; Aljama P
Nephrol Dial Transplant; 2012 Jul; 27(7):2907-12. PubMed ID: 22247233
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
